Communiqué of GTTAC meeting 28 February 2018
This Communiqué covers matters considered at the 14th video conference of the Gene Technology Technical Advisory Committee (28 February 2018).
Dealings involving the Intentional Release (DIR) of a GMO can involve a limited and controlled release (clinical trial or field trial) or a commercial (general) release.
The Regulator must seek GTTAC advice during the preparation of a RARMP for DIR applications which do not qualify as limited and controlled under Section 50A of the Act. The Regulator must also seek advice from GTTAC on RARMPs that have been prepared for all DIR applications.
The RARMP for every DIR licence application is issued for public consultation. Information on how to obtain copies of DIR applications and RARMPs is provided in this document.